Skip to main content

Advertisement

SpringerLink
Log in

Hepatitis B Virus Vaccine for Patients with Hepatitis C Virus Infection

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Summary

Hepatitis C is a disease with varying rates of progression. The role of hepatitis B virus (HBV) as a cofactor in the development of hepatitis C virus (HCV)-related cirrhosis and hepatocellular carcinoma (HCC) has been suggested and the use of HBV vaccine in all HCV-infected patients has been advocated. This review presents the implications of HBV and HCV coinfection and addresses the issues of HBV vaccine immunogenicity and safety in patients with chronic HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Dept. of Infectious Diseases, Medical Academy of Bialystok, Zurawia 14, P-15-540 Bialystok, Poland, Phone: (+48/85) 7416-921, Fax: -921, e-mail: doctors@friko.onet.pl, , , , , , PL

    S. Chlabicz & A. Grzeszczuk

Authors
  1. S. Chlabicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Grzeszczuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: December, 1999 · Revision accepted: July 1, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chlabicz, S., Grzeszczuk, A. Hepatitis B Virus Vaccine for Patients with Hepatitis C Virus Infection. Infection 28, 341–345 (2000). https://doi.org/10.1007/s150100070002

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s150100070002

Search

Navigation